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Abstract
Background: Although several studies have reported the direct cost of oral cancer (OC), little research has invested the 
factors that could influence the costs of OC patient. This study analyzes the epidemiological characteristics and the 
direct cost of OC. More specifically, the study examines the relationship between patients' medical costs and 
influencing factors of epidemiology.
Methods: All patients encountered from January 2007 to December 2007 at the School of Stomatology of the Fourth 
Military Medical University (FMMU) in China with diagnosis of oral cancer have been selected. Medical hospitalization 
days (MHD) and cost per patient (CPP) of the samples have been calculated for different patient groups, and the results 
have been compared using statistical methods.
Results: A total of 456 oral cancer patients have been selected in this study. The epidemical characteristics are as 
follows: female/male 176/280; squamous cell carcinoma (SCC)/adenocarcinoma/sarcoma/lymphoma/other types 246/
127/40/27/16; stage I/II/III/IV 90/148/103/115; smoker/non-smoker 136/320; rural/urban patients 82/374. Of all the 
patients, 82.24% were over 40 years of age. Rural patients were significantly younger than urban patients. SCC was the 
majority histology in older patients, while sarcoma was more common in younger patients. 372 of the patients 
received treatment and 84 gave up any treatment after diagnosis. Treatment cost accounted for majority of the 
payment. The CPP and MHD of patients in late clinical stage were higher than that of patient in early stage.
Conclusion: Gender, smoking habit and age older than 40 years are the epidemiological risk factors for oral cancer. 
Lack of medicare, smoking habit, late clinical stage and SCC are the high economic factors for patient medical cost.
Background
Oral cancer has been recognized as a huge threat to pub-
lic health because of its high morbidity and mortality. It is
estimated that each year there are over 484,000 people
diagnosed with oral cancer in the world and approxi-
mately 261,000 people die of this disease [1]. In China,
over 11,900 cases of oral cancers are diagnosed each year
and approximately 5,000 patients die of the disease [1]. A
number of factors are associated with the increase of risks
of oral cancer. The risk factors include age, tobacco and
alcohol consumption, human papilloma virus infection,
and race, etc [2-4].
Primary treatments of oral cancer include surgery, radi-
ation and chemotherapy [3,5,6]. These treatments can be
employed alone or in combination depending on the clin-
ical stage and histology of oral cancer. Beside primary
treatments, oral cancer patients may require additional
care to ameliorate the side effects of treatment, such as
oral pain due to the tumor or oral mucositis, weight loss,
fatigue, nausea, vomiting, and altered salivary gland func-
tion [7,8]. Owing to the increasing morbidity and mortal-
ity of oral cancer, the treatment costs increase fast. In
China, the costs for treating oral cancer bring a heavy
financial burden to both social resources and patient's
family. On top of direct cost for diagnosing, treatment,
and hospitalization, indirect cost includes loss of produc-
tivity of patients due to morbidity and disability is very
difficult to define and calculate. Given that a patient's
medical bill does not reflect all the cost of his or her treat-
ment, in this study, we chose to use inpatients' medical
bill as major evidence to indicate the rough cost of their
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treatment [9]. The information of patients' direct costs
can be retrieved from the database of the hospital's infor-
mation system, which archives the detailed medical cost,
doctors' administrations, and case files. To date, few stud-
ies have been conducted to assess the medical cost for
oral cancer treatment and its relationship with the
increasing risks of oral cancer.
This study examines the direct cost of treatment of oral
cancer in different stages and analyzes the relationship
between patients' medical costs and the related factors
including gender, age, clinical stage, pathology, and smok-
ing habit. Furthermore, this study also analyzes the fac-
tors of medicare and census register because they can
enable us to better understand the economic pressure to
patients and also help medical administrators, doctors,
and patients to make care plans and treatment decisions
appropriate to the needs of patients and their families.
Methods
Patients
The study included two parts: epidemiological study and
cost analysis. All samples for this study were selected
from the Stomatology Hospital of FMMU in China. The
data were retrieved from the database of this hospital.
The observation period for each patient was 12 months,
from January to December 2007. The patients were
observed from their first visit to the hospital until the end
of year. Epidemiological study included the patients who
were diagnosed as having malignancies of the oral cavity
including tongue, floor of the mouth, buccal mucosa, gin-
gival tissues, retromolar trigon, palate, and lips with path-
ological evidences. Cost analysis study included those
who had received at least one of the following treatments:
surgery, chemotherapy and radiotherapy. Patients who
gave up treatment in the Stomatology Hospital of FMMU
or who chose to receive treatment in other hospitals were
not included in the cost analysis study. This study was
approved by the Ethics Committee of the School of Stom-
atology of the Fourth Military Medical University.
Data Analysis
Data for epidemiological study included age, gender,
pathology, clinical stage, and smoking habits. Data for
cost analysis included the cost for diagnosing, treatment,
and hospitalization. Diagnosing cost encompasses
pathology, radiation, and laboratory testing; treatments
cost includes surgery, chemotherapy, radiotherapy, and
concomitant medications; and hospitalizations cost goes
to nursing, supportive care and lodging.
The cost was calculated in Chinese Yuan (RMB). The
charge for every item of service and medication was set
by the Price Administration Bureau, and the fees were
similar in same grade hospitals as the FMMU hospital.
Considering there was no subsidy in the billing record in
the FMMU hospital, there was no need to fix the cost bias
as had to be done in some other studies.
Statistical analysis
Continuous variables are presented with mean and stan-
dard deviation, while discrete variables are presented
with absolute and relative frequencies. Chi-square tests
were used for the comparisons of proportions. Student's
t-tests were computed for the comparison of mean val-
ues. Differences on CPP(cost per patient) and
MHD(medical hospital days) according pathology were
determined by analysis of variance(ANOVA). The differ-
ences on the costs of diagnose, treatment and inpatient
according pathology were also determined by ANOVA.
Risk factors for squamous cell carcinoma (SCC) were
d e t e r m i n e d  b y  a n a l y s i s  o f  l o g i s t i c  r e g r e s s i o n  w h i l e  t h e
variables for CPP were determined by multiple liner
regression. Adjusted odds ratios with 95% confidence
intervals were computed from the results of the logistic
regression analyses. All p-values reported are two-tailed.
Statistical significance was set at 0.05 and SPSS 17.0 was
employed to perform all of the analyses.
Results
Epidemiology
During the period of 2007, Stomatology Hospital of the
FMMU received a total of 456 new patients (176 females,
280 males) that had been previously diagnosed with oral
cancer. The pathologies of this group of samples included
SCC, lymphoma, adenocarcinoma, sarcoma and others.
Cytoma, small cell carcinoma, melanoma and clear-cell
carcinoma were put into "others" category for their rarity.
Of the 456 oral cancer patients, 53.9% (246/456) were
SCC; 27.85% (127/456) were adenocarcinoma; 8.77% (40/
456) were sarcoma; and 5.92% (27/456) were lymphoma.
According to the TNM stage (WHO for Staging Oral
Cancer), 32.46% (148/456) were diagnosed at stage II,
25.21% (115/456) at stage IV, 22.59% (103/456) at stage III
and 19.74% (90/456) at stage I. 29.82%(136/456) patient
had smoking habit while 132 were male and 4 were
female (table 1). Of the 136 smoking patients, 69.85% (95/
136) got SCC, 17.65% (24/136) got adenocarcinoma, and
12.50% had other pathology types such as lymphoma, sar-
coma.
This study also analyzed the gender distribution in dif-
ferent clinical stages (figure 1A). In stage I and II, the pro-
portion of male and female were comparatively even
(58.89% vs. 41.11%, and 52.7% vs. 47.3% respectively). But
in stage III and IV, the proportion of male was obviously
higher than female (67.96% vs. 32.04%, and 68.7% vs.
31.3% respectively). The stage distribution features in
male and female groups were also different (figure 1B).
Male distribution in each stage was comparatively even
(19%, 28%, 25%, 28%), while a majority of female patientsHan et al. BMC Public Health 2010, 10:196
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distributed in stage II (40%). Findings also indicated that
SCC and adenocarcinoma were the most common
pathologies in both male and female group (figure 1C).
The proportion of adenocarcinoma in female group was
higher than that in male group (34.09% vs. 23.93%), while
the proportion of SCC in female group was lower than
that of male group (48.86% vs. 57.14%).
As tobacco smoking is the most important risk factor
for oral cancer, the pathology distribution was examined
in the total sample and smoker group respectively (Figure
2). Compared with the total sample, the proportion of
SCC in smoker group was relatively high compared with
other the non-smoker samples (69.85% vs. 53.95%), while
adenocarcinoma, lymphoma and sarcoma shared the low
proportions (17.65% vs. 27.85%; 3.68% vs. 5.92%; 5.14%
vs. 8.77% respectively) (figure 2A). Table 2 showed that
the proportion of male smokers in late stage (III and IV)
was evidently higher than that in early stages (I and II)
(figure 2B) and the proportion of male smoker with SCC
was evidently higher than that with adenocarcinoma.
The mean age of the total 456 samples was 54.63 ±
16.73 years (range 1-90 years). There was no evident dif-
ference between male and female group about mean age
(Figure 3A and Table 3). Of the 456 patients, 17.98% (82/
456) patients came from rural areas, and 82.02% (374/
456) came from urban. The mean age of the rural and
urban patients was 48.56 ± 16.79 and 55.94 ± 16.54
respectively, indicating a significant statistical difference
(p < 0.01) (figure 3B and Table 3). The mean age of early
and late clinical stages showed no significant difference
(Figure 3C and Table 3).
We have further probed into the relationship between
different age ranges and pathology (Table 4). The total
samples were divided into four age range groups: < 20
years, 20~39 years, 40~59 years, and ≥ 60 years. Nearly
82.24% (375/456) patients were older than 40 years of age,
and 3.07% (14/456) were under 20 years of age. The pro-
portion of SCC was higher in the age group of over 59 but
rare in the young group (< 20 years). The proportion of
adenocarcinoma was relatively higher in the age group of
40-59 (48.83%).
Table 5 showed the logistic regression analysis of inde-
pendent factors of SCC and adenocarcinoma. The results
showed that smoking habit and age were independently
Table 1: Sample characteristics
n%
Gender
Male 280 61.40
female 176 38.60
Clinic stage
I 90 19.74
II 148 32.46
III 103 22.59
IV 115 25.21
Smoking status
Yes 136 29.82
No 320 70.18
Pathology
SCC 246 53.95
Adenocarcinoma 127 27.85
Sarcoma 40 8.77
Lymphoma 27 5.92
others 16 3.51
Census register
urban 374 82.02
rural 82 17.98
Receive any treatment
yes 372 81.58
no 84 18.42Han et al. BMC Public Health 2010, 10:196
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a s s o c i a t e d  w i t h  S C C.  P a t i e n t s  w i t h  s m o k i n g  h a b i t  h a d
3.032 times greater odds (95%CI: 1.565-5.872) for SCC
than non-smoking patients. The odds for SCC were 3.231
times higher for patients older than 40 compared with
patients younger than 40 years old.
Cost Analysis
The primary goal of cost analysis in the study was to iden-
tify the relationship of differences in MHD and CPP with
pathology, clinical stage, gender, smoking habit, medicare
and census register.
Of the all the patients selected to this study, 372
patients had received at least one of the three treatments,
surgery, radiation and chemotherapy, and 84 patients
chose not to receive any treatment in this hospital.
89.20% of those who received treatments in this hospital
did not have medicare (332/372); only 10.80% of them
(40/372) were covered with medicare.
Gender, medicare, rural/urban factor, smoking habit
Statistical results indicated no significant difference
between the MHD of male and female (p = 0.19). How-
ever, the CPP of male was significantly higher than that of
female (p = 0.039) (Table 6, Figure 4A). No significant dif-
ference was found in the MHD between the patients with
medicare and those without medicare (p = 0.628). Inter-
estingly, the CPP of those with medicare were evidently
lower than those without medicare (p = 0.002) (Table 6,
Figure 4B). This study has also found that whether the
patients came from the country or the cities, the MHD
and CPP showed no evident difference (Table 6, Figure
4C).
Smoking habit is a crucial factor in the development
and prognosis in oral cancer. Therefore, this study sought
to ascertain whether or not smoking habit could affect
the direct cost for this disease. Table 6 and Figure 4D
demonstrate that the MHD and CPP of smokers were sig-
nificantly higher than those of non-smokers (p = 0.018).
Considering the higher proportion of smokers in the
male than female group, the MHD and CPP of patients in
male non-smoker samples were compared with the
female group. The MHD and CPP in the two groups
showed no evident difference (p = 0.898, p = 0.326) (Table
6 and Figure 4E).
Figure 1 proportion of gender clinic stage and pathology propor-
tion in the sample data. Figure 1A gender distribution proportion in 
different stage. Figure 1B stage distribution proportion in male and fe-
male group respectively. Figure 1C pathology distribution in male and 
female group respectively.
Table 2: The results of comparison of proportion of male smoker in different clinic stage and pathology with the chi-
square test
Smoking status p
No Yes
Sample Percent% Sample Percent% χ2 test
stage 0.019
I,II 79 60.31 52 39.69
III,IV 69 46.31 80 53.69
Pathology 0.001
SCC 67 41.86 93 58.14
Adenocarcinoma 44 65.67 23 34.33
Note: Female patient were not calculated because there were only 4 female smokers in the sample. For the same reason, only male patient 
with SCC or adenocarcinoma were compared in the table.
Figure 2 proportion of smoking patient in the sample. Figure 2A 
pathology distribution in the total sample and smoker group respec-
tively. Figure 2B clinical stage distribution proportion in the smoker 
group.Han et al. BMC Public Health 2010, 10:196
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The total cost for oral cancer treatment is comprised of
three parts: diagnosis, treatment and hospitalization. Fig-
ure 5 indicates that treatment accounts for the major
cost. In terms of overall cost, there was no difference
between rural patients and urban patients (Figure 5B and
Table 7). Table 7 also indicates that the cost for diagnosis
and hospitalization in both gender groups had no signifi-
cant difference (p > 0.05), however, the treatment cost of
the male patients was significantly higher than the female
patients (p = 0.015) (Figure 5A, Table 7). Although, there
was no evident difference between patients with medi-
care and without medicare in hospitalization, it is notice-
able that the diagnosing and treatment cost for patients
with medicare was significantly lower than those without
medicare (Figure 5C, Table 7). Comparing the cost of
smokers with non-smokers, there was no difference in
the cost diagnosing between these two groups, however,
the smokers had significantly higher cost for treatment
and hospitalization than those non-smokers, (Figure 5D,
Table 7).
Stage and Pathology
We examined the detailed MHD and CPP of patients in
different clinical stage and with different pathology. Table
6 indicate that the MHD and CPP of patients in early clin-
ical stages (I~II) were lower than those in late stages
(III~IV). Table 8 showed the comparison of MHD and
CPP between different pathology groups. The CPP and
MHD of adenocarcinoma group were evidently lower
than that of SCC and sarcoma group. There were no sig-
nificant different in MHD and CPP between SCC and
sarcoma group.
The study has further analyzed the costs for diagnosis,
treatment and hospitalization in different clinical stages
(Figure 6A, Table 7). The findings showed that the cost
for diagnosing, treatment and hospitalization in early
stage were significantly lower than those in late stage
(Table 7).
The data indicated that the cost for diagnosis in each
pathology group had no evident differences (p > 0.05).
The treatment cost in adenocarcinoma group was signifi-
cantly lower than that of SCC groups. The hospitalization
cost of adenocarcinoma group was significantly lower
than that of SCC and sarcoma group. (Figure 6B, Table 9).
Variables for cost
To determine the independent variables for the costs of
OC patient, multiple regression was made. Table 10
showed that medicare, pathology and clinical stage were
associated with the cost of OC patient. Age, smoking
habit, gender and census register were not the indepen-
dent variables for the cost of OC patient.
Discussion
Epidemiological Characteristics and Risk Factors
According to report that the incidence of oral and pha-
ryngeal cancer is increasing to be the 8th most common
malignancy worldwide [1]. Numerous studies have
already identified cigarette smoking as an important fac-
tor to the cause oral cancer [3,10-12]. This study has also
Table 3: The results of comparison of mean age in different groups with t-test
± S
pn
Gender
male 55.06 ± 17.15 0.598 280
female 54.08 ± 16.26 176
Rural/Urban
Rural 48.56 ± 16.79 0.000 82
Urban 55.94 ± 16.54 374
Stage
I,II 54.51 ± 16.31 0.823 238
III,IV 54.87 ± 17.35 218
X
Figure 3 media age in different groups. Figure 3A median age of 
male and female group. Figure 3B median age of rural and urban 
group. Figure 3C median age in different clinical stages. Figure 3D me-
dian age in different pathology types.Han et al. BMC Public Health 2010, 10:196
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Table 4: Age distribution in different pathology
Age range n(%)
<20 20~ 40~ >60 total
Pathology
sarcoma 8(20) 13(32.5) 12(30) 7 (17.5) 40(100)
SCC 0(0) 19(7.72) 88(35.77) 139(56.51) 246(100)
lymphoma 4(14.81) 5 (18.52) 7(25.93) 11(40.74) 27(100)
adenocarcinoma 2(1.57) 29(22.83) 62(48.83) 34(26.77) 127(100)
Table 5: results of logistic regression that evaluate age, gender, smoking habit and census register factors in relation to 
SCC
OR(95% CI) p
Gender 1.164(0.675-2.008) 0.5854
Smoking habit 3.032(1.565-5.872) 0.0010
Age 3.231(1.622-6.436) 0.0009
Census register 1.020(0.570-1.827) 0.9457
Note: only SCC and adenocarcinoma patient was selected for the analysis because of the rarity of the others pathology groups.
Table 6: The result of comparison of MHD and CPP in different groups with t-test
MHD(days) CPP(RMB)
 ± S
p
 ± S
p
Gender
male 32.31 ± 11.22 0.19 25890.46 ± 9663.03 0.039
female 29.55 ± 10.74 22071.86 ± 8537.38
Smoking
smoker 35.07 ± 11.89 0.018 27580.14 ± 9721.63 0.025
non-smoker 29.67 ± 10.60 23085.26 ± 9174.67
male non-smoker 29.86 ± 11.35 0.898 24149.55 ± 9284.89 0.326
female 29.55 ± 10.74 22071.86 ± 8537.38
Medicare
medicare 29.84 ± 9.97 0.628 18217.54 ± 8933.08 0.002
non-medicare 31.39 ± 11.91 25193.69 ± 9652.72
Censue register
rural 31.44 ± 10.17 0.896 24165.41 ± 8141.78 0.901
urban 31.12 ± 9.78 24425.96 ± 8424.43
Stage
I,II 27.25 ± 10.74 0.000 19544.09 ± 7412.78 0.000
III,IV 35.96 ± 12.67 30163.82 ± 9039.12
X XHan et al. BMC Public Health 2010, 10:196
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confirmed the relationship between SCC and smoking.
Although the proportion of SCC in the total sample was
the highest (53.95%), it was particularly higher in the
smoker group, accounting for nearly 70%. Our study indi-
cates that smoking habit significantly correlates the
smoking patients to late clinical stage. The proportion of
smoking patients in late stage was higher than that in
early stage, and this may mean poor prognosis [12].
Therefore, the high risk factor of cigarette smoking
should be widely acknowledged.
The result of this study has shown the occurrence of
oral cancer in male population was higher than in female
population. Males were more affected by oral cancer
because of their exposure to carcinogenic factors associ-
ated with this tumor, such as tobacco and alcohol [3,10-
12]. No median age differences existed between men and
women, and this is in agreement with previous reports
[13]. Regarding the distribution of pathology over the
clinical stages, the incidence of male in every stage, par-
ticularly in late state, was higher than that of female.
Compared with the male patients, the female patients
were more diagnosed in early stage (p = 0.004), indicating
better prognosis. Although SCC and adenocarcinoma
were the most common pathologies in both male and
female groups, the proportion of SCC in female was
lower than in male group. This phenomenon can proba-
bly also be explained by smoking habits.
The age information in the sample patients indicates
that oral cancer is more common among the elderly. Of
the 456 patients, 196 were over 60 years of age; only 14
were under 20 years of age. The patients under 40 years of
age were less than 1/5 of the total, while those over 40
were more than 4/5 of the total. This result, which is sim-
ilar to the results reported in other studies [14], indicates
that doctors should pay more attention to patients over
40 years of age and suggest that these patients receive oral
examination on a regular basis. Regular oral examination
can help identify oral cancer at early stage. Treatment
delivered at early oral cancer stage can improve patients'
survival opportunity and reduce their medical expenses.
Some investigators have reported poor prognosis for
older patients [15-17] and came to the conclusion that
late clinical stage means poor prognosis. In our study, we
analyzed the relationship between clinical stage and
median age. The result has shown that there were no sig-
nificant differences between early and late clinical stage
groups. The study has also found that SCC was more
common in older patients, that is, confirming the associa-
tion with older patients and the higher incidence of SCC.
This may also be related to smoking, because cigarette
smoking was more prevalent in the older-age group and
has resulted in a significantly increased risk of SCC in
many tissues and organs such as oral, lung and esophagus
[18]. However, the incidence of sarcoma decreased with
the increase of age, and this may be related to the high
incidence of soft tissue carcinoma in younger people
[19,20]. It seems that adenocarcinoma mainly exists in
middle age patients, and the reason for this remains to be
explored in future studies.
The mean age of rural patients was significantly
younger than that of urban patients. This may be related
to the oral hygienic habits in rural areas. For example, a
recent study of 103 oral cancer patients in Russia reveals
that people living in the country had fewer teeth-brush-
ing on a daily basis than people living in the city, and rural
patients had oral cancer at an earlier age than urban
patients [21]. The results of this study support this evi-
dence, but the high oral cancer risk at earlier ages among
rural populations is probably related not only to the poor
hygienic habits of rural people but also to the poor
hygienic environment of the rural area. Owing to poverty
and lack of clean water, some rural residents in the west
China may experience difficulty with good oral hygienic
habits. In future research, more efforts should be directed
to rural hygienic environment and personal oral hygienic
habits. Lack of knowledge about oral cancer also
increases the risk of oral cancer development. Although
oral cancer can easily be found by patients through a per-
sonal oral examination, many patients ignore it and some
doctors do not pay enough attention [22]. Doctors' igno-
rance of oral cancer can often result in a delay of an offi-
Figure 4 MHD and CPP associated with gender, medicare, censue 
register and smoking habit.Han et al. BMC Public Health 2010, 10:196
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cial oral cancer diagnosis. Based upon this information, it
is necessary to introduce more knowledge of oral cancer
to both ordinary people and health care providers.
The logistic regression analysis showed the smoking
habit and age were the independent risk factors for SCC
(Table 5). Although gender was not the independent risk
factor in the analysis, it should still be noticed for almost
all smokers of the study were male. The proportion of
female smoker was very low in china, so the gender factor
should also be paid attention by the dentist.
Economic characteristics and related factors
In China, with the increasing cost for cancer, health care
administrators and researchers have paid more attention
to healthcare economics. In recent years, some research-
ers have investigated the cost related to clinical stage, age,
etc. of oral cancer [23-25]. However, these studies did not
include other contributory cost factors such as gender,
smoking habit, and pathology. The aim of this study is to
find and analyze the epidemiological characteristics and
direct medical costs of oral cancer in China. Findings
from this study support and further enhance previous
findings on the cost of treating oral cancer.
An earlier study has reported that non-smoker patients
at any age may have a worse clinical outcome, and the
researchers suggested that this group of patients be eval-
uated for unique genetic and environmental etiologies,
and should probably be approached in a more aggressive
fashion [26]. However, the result of our study came to a
different conclusion. The cost differences mainly existed
in treatment and hospitalization but not in diagnosis.
There was no difference in MHD and CPP between male
non-smokers and female non-smoker groups; however,
the MHD and CPP of smokers were significantly higher
t h a n  t h o s e  o f  n o n - s m o k e r s .  T h i s  r e s u l t  i n d i c a t e s  t h a t
clinical outcomes are more related to smoking habit of
oral patients than to gender.
The treatment cost for male patients was significantly
higher than female patients although the MHD was com-
parative. This may have two explanations. One explana-
Table 7: The result of comparison of mean cost of diagnosis, treatment and hospitalization in different groups with t-test
Diagnosis Treatment Hospitalization
 ± S
p
 ± S
p
 ± S
p
Gender
male 3366.87 ±
1200.11
0.78 18437.64 ±
7680.07
0.015 4085.95 ±
1331.44
0.071
female 3472.55 ±
1330.50
15034.64 ±
6947.31
3564.67 ±
1199.15
Censue 
register
rural 3484.04 ±
880.37
0.816 17054.52 ±
8800.5
0.987 3626.85 ±
1288.04
0.309
urban 3384.34 ±
1119.73
17081.32 ±
8159.8
3960.31 ±
1522.72
Medicare
yes 2360.03 ±
1165.69
0.000 12294.71 ±
6546.36
0.002 3562.81 ±
1141.77
0.414
no 3551.40 ±
1277.87
17722.52 ±
8625.68
3955.21 ±
1407.36
Smoking
yes 3502.53 ±
1056.91
0.751 19632.98 ±
7443.40
0.023 4444.63 ±
1402.97
0.011
no 3372.21 ±
1219.56
16060.77 ±
7175.36
3652.28 ±
1263.66
Stage
I,II 2814.56 ±
795.47
0.000 13396.73 ±
7596.94
0.000 3332.8 ±
1386.07
0.000
III,IV 4125.54 ±
964.92
21505.33 ±
8272.4
4532.95 ±
1706.4
X X XHan et al. BMC Public Health 2010, 10:196
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t i o n  i s  t h a t  t h e  f e m a l e  p a t i e n t s  w e r e  d i a g n o s e d  m o r e
frequently in early clinical stage than male patients. The
findings of two studies respectively conducted in Greece
and the United States support this observation that the
average cost in late stages (III~IV) was evidently higher
than that in early stages (I~II)[23,25]. This study has also
confirmed this conclusion. In the current study, the CPP
in late stages was nearly twice more than that in early
stages, and the MHD in late stages was also longer than
that in early stages. The high cost for treatment is related
to the advanced stage of cancer because patients need
more extensive and aggressive treatment. Therefore, early
detection may increase diagnose rate, and early treatment
may decrease the total cost for oral cancer patients.
The other explanation for a higher cost of male oral
cancer patients is the higher proportion of SCC in male
patients than in female patients. We make this new argu-
ment based on our study and analysis of the samples of
different pathology. Within the two main types of oral
cancer (SCC, adenocarcinoma) in this study, the CPP of
SCC was higher, and the CPP differed mainly in treat-
ment and hospitalization. This can partially explain why
the cost for female patients was lower than that of male
patients.
What is more, the analysis in this study has also
included cost differences between patients with and with-
out medicare and between rural patients and urban
patients. According to our study, the cost of the rural
patients was similar to that of the urban patients, but the
former paid more because of the low coverage rate of
medicare in rural areas in China. The coverage of medi-
care in China has been expanded fast in recent years;
however, there are still a lot of patients, particularly in
rural areas, who had to afford their medical treatment by
themselves. The burden of medical bill for oral cancer
treatment was heavier to patients in rural than in urban.
Our data showed that 12.53% of the urban patients were
covered by medicare while only 1.23% of the rural
patients were supported with medicare. Further analysis
has revealed that the cost difference mainly existed in
diagnose and treatment, but not in hospitalization. In
China, some examinations, drugs and treatment mea-
sures are not covered by medicare, and the costs incurred
by these items should be paid by patients themselves. In
order to reduce this kind of costs, doctors and patients
would tend to choose those items covered by medicare.
For non-medicare patients, their examination and treat-
ment were not limited by medicare regulations, so doc-
tors and patients would choose the most effective and
safe items to diagnose and treat oral cancer, and thus
would directly cause the increase of medical costs.
Although the medicare coverage list expands in recent
years, more sophisticated and comprehensive treatment
and more effective medicines should be added on the
medicare list.
T h e  r e s u l t  o f  m u l t i p l e  r e g r e s s i o n  s h o w e d  t h a t  t h e
smoking habit was not the independent factor for the cost
of OC patient. But the proportion of smoker in late stage
was higher than that of early stage and the proportion of
Figure 5 Diagnose, treatment and hospitalization cost associat-
ed with gender, censue register, medicare and smoking habit.
Table 8: ANOVA analysis of MHD and CPP with different pathology
MHD(days) CPP(RMB)
 ± S
ANOVA
 ± S
ANOVA
Pathology F = 14.865
p = 0.000
F = 9.643
p = 0.000
SCC 35.24 ± 13 # 27889.93 ± 11031.95 #
sarcoma 38.27 ± 12.81 # 27635.03 ± 10647.21 #
adenocarcinoma 23.61 ± 10.27 * ^ 19222.25 ± 9222.52 * ^
Note: lymphoma and other group were not calculated for their rarity
*: significant different with SCC
^: significant different with sarcoma
#: significant different with adenocarcinoma
X XHan et al. BMC Public Health 2010, 10:196
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smoker in SCC was obviously higher than other group.
These results indicated that smoking were associated
with stage and pathology of OC and would associate with
the cost of OC patient indirectly.
Conclusion
Although this study has not explored many other factors
such as pathological grade, longer time cost analysis, sur-
vival rate and so on, which need to be further studied, the
following conclusions may be drawn: (1) Smoking is an
important risk factor that is not only related to develop-
ment of oral cancer, but also increases the total cost and
medical hospitalization days for oral cancer patients; (2)
Gender, smoking habit and age are the related factors for
oral cancer; (3) The median age of rural patients was
younger than that of urban patients; (4) The proportion
and cost for SCC were higher than those of adenocarci-
noma. (5) The MHD and CPP in late clinical stage were
higher than those in early stage. (6) The CPP of patients
without medicare was higher than those with medicare.
To reduce the economic loss to oral cancer patients and
to social resources, it is crucial that oral cancer can be
identified and treated at its early stage. Physicians must
be aware of the possibility of oral cancer, particularly
among those with high risk factors and premalignant oral
lesions such as leukoplakia. To reduce morbidity and
Figure 6 Diagnose, treatment and hospitalization cost associated with clinical stage and pathology.
Table 9: ANOVA analysis of cost of diagnosis, treatment, and hospitalization in different pathology
Diagnosis Treatment hospitalization
 ± S
ANOVA
 ± S
ANOVA
 ± S
ANOVA
Pathology F = 0.006
p = 0.994
F = 10.831
p = 0.000
F = 12.746
p = 0.000
SCC 3465.22 ±
1058.89
19995.22 ±
9700.83
# 4429.49 ±
1618.05
#
sarcoma 3437.07 ±
1027.85
17064.89 ±
7305.06
4309.36 ±
1026.71
#
adenocarcino
ma
3507.06 ±
1221.29
12787.87 ±
4798.98
* 2927.32 ±
683.41
* ^
Note: lymphoma and other group were not calculated for their rarity
*: significant different with SCC
^: significant different with sarcoma
#: significant different with adenocarcinoma
X X XHan et al. BMC Public Health 2010, 10:196
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mortality attributable to oral cancer, greater efforts
should be made for prevention. Primary prevention of
oral cancer includes avoidance of tobacco use and alcohol
abuse, appropriate intake of fruit and vegetables, and
good oral hygienic habits. In addition, people should be
routinely screened for oral mucosal lesions, which is
essential for early detection.
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